Why Genpact (G) may be catching investor attention

Genpact (G) has drawn fresh interest after a period where the stock has declined over the past 3 months and year to date, despite reporting revenue of US$5.2b and net income of US$569.6m.

At a share price of US$32.63, Genpact’s short term share price returns have been weak, with the stock down 15.8% over the past 90 days and 28.9% year to date, while the 5 year total shareholder return is also negative. This suggests momentum has been fading over both shorter and longer horizons.

If you are weighing up Genpact’s recent pullback and want to broaden your watchlist, now could be a useful moment to scan the market for 20 top founder-led companies

With Genpact trading at US$32.63, an intrinsic value estimate implying a 71.9% discount and a 30.1% gap to the average analyst target, you need to ask: is this a genuine opportunity, or is the market already adjusting for future growth?

Most Popular Narrative: 23.1% Undervalued

Genpact's most followed narrative places fair value at $42.45, well above the recent $32.63 close, which puts the current sell off in sharper context.

Genpact's strong pipeline, particularly in high-growth verticals like high tech, manufacturing, and financial services, combined with increasing large-deal activity and stable operating leverage, sets the stage for above-sector-average revenue and EPS growth, aided by operating margin expansion and continued return of capital to shareholders.

The heart of this narrative is a revenue and earnings path that leans on higher margin AI led services, richer contracts, and a tighter share count. Curious which specific growth, margin and valuation assumptions have to line up for that $42.45 fair value to hold up? The full narrative lays out those moving parts in detail.

Result: Fair Value of $42.45 (UNDERVALUED)

However, this depends on AI-led services and large multi-year contracts delivering as planned, and on legacy outsourcing not dragging growth and margins off course.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Next Steps

With sentiment mixed and the valuation debate wide open, this is a moment to move quickly, check the data yourself, and decide if the potential rewards justify the risk, starting with the 4 key rewards.

Looking for more investment ideas?

If Genpact is already on your radar, do not stop there. Use the screener to surface other focused ideas that might deserve a closer look alongside it.

• Hunt for potential mispricings by scanning a curated set of 46 high quality undervalued stocks that pair quality fundamentals with appealing valuations.
• Stack your income watchlist with 9 dividend fortresses if you want stocks that put regular cash returns at the center of your portfolio.
• Sleep easier by reviewing 63 resilient stocks with low risk scores designed for investors who prefer resilience and steadier risk profiles over big swings.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.